A news website on Indian venture capital, private equity, mergers and acquisitions

Visit VC Circle

Everest Capital, CVCI Invest $24 Million In Nectar Lifesciences

Posted on August 25, 2008

Citi Venture Capital International (CVCI) and Everest Capital (M) Ltd have invested $23.6 million in pharmaceutical major Nectar Lifesciences. While Everest Capital led the round with an invesment of $21.2 million, CVCI has invested $2.36 million. The stake has been sold at a price of Rs 346 per share, as against its closing price today of Rs 359. While Bermuda based Hedge Fund Everest Capital will hold 14.6 % stake, CVCI will hold 1.56% stake. The promoters stake in post issue capital would fall to 54% from 64.5%.read more...

Original article link


venture capital